GVK Biosciences (GVK BIO) is one of Asia’s leading Discovery Research and Development organizations. GVK BIO provides a broad spectrum of services, across the R&D and manufacturing value chain with a focus on speed and quality. GVK BIO capabilities include Integrated Programs, Discovery Services, Clinical Development, Contract Manufacturing, Formulations and Informatics.
GVK BIO has over a decade of rich experience in providing breakthrough drug discovery and development services. Our team of scientists, backed by well-laid processes and cutting edge technologies, enable customers to achieve unmatched results.
GVK BIO’s 2400 employees serve a diverse and global customer base of more than 300 satisfied customers. We have consistently exceeded our customers’ expectations in terms of quality, speed and affordability. Precisely why, our clientele who are among the global top 10 in the fields of Pharmaceutical, Agrochemical, Electronics, Biotechnology and Academics entrust us with their research challenges.
GVK BIO’s scientific talent pool with over 1800 scientists and 200 PhD’s makes it a leading life sciences company in India. Spread across five locations in India, GVK BIO has dedicated lab space of >500,000 sq.ft and manufacturing capabilities spread across 17 acres of land. GVK BIO is today India’s premier Contract Research Organization, providing an integrated platform for research services across the Pharma R&D value chain.
In January, 2014 GVK BIO acquired Aragen Bioscience, Inc., a privately held US-based preclinical CRO specializing in high value biologics services, thereby positioning GVK BIO as a leading provider of integrated R&D services across both large and small molecule platforms.
GVK BIO is part of the GVK Group, India’s largest conglomerate, with wide experience and expertise spanning across areas such as Infrastructure, Energy, Resources, Airports, Transportation, Hospitality and Life Sciences.